Participate in On Demand Activity
	Activity Details PDF
	Course Materials PDF (online credit only)
	Download Slides
	Subscribe to Podcast
	Download MP3 File
	Complete Post-Test/ Print CE Certificate

	Faculty
	Statement of Need
	Activity Goal
	Learning Objectives
	Target Audience
	Financial Support
	Credit Information

neuroscienceCME Webcast

Premiere Date: Tuesday, November 17, 2009

This activity offers CE credit for:

1. Physicians (ACCME/AMA PRA Category 1)
2. Nurses (CNE)
3. Pharmacists (ACPE)
4. Psychologists (APA)
5. Social Workers (NASW)
6. Certified Case Managers (CCMC)

All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
Credit Expiration Date:
Wednesday, November 17, 2010

Faculty

Claudio N. Soares, MD, PhD, FRCPC  Associate Professor Department of Psychiatry and Behavioural Neurosciences Department of Obstetrics and Gynecology Academic Head, Mood Disorders Division McMaster University Director, Women’s Health Concerns Clinic St. Joseph’s Healthcare and McMaster University Hamilton, ON

Jonathan D. Adachi, BSc, MD, FRCP  Professor of Medicine Head, Division of Rheumatology Michael G. DeGroote School of Medicine McMaster University Hamilton, ON

Statement of Need

A woman’s midlife transition from peri-menopause through post-menopause brings a period of vulnerability for physiologic and symptomatic changes affecting both physical and mental health. Estrogen has multiple effects on neurotransmitter systems and brain regions including the hypothalamus, neocortex, hippocampus, and brainstem. During times of estrogen fluctuations and decline, dysregulation of neuroendocrine systems can lead to physiologic effects such as hot flashes, reduced bone mass, and depression. In a recent online survey from The Menopause Epidemiology Study, the reported prevalence of VMS, including hot flashes, night sweats, and sleep disturbances, was 79% in peri- and 65% in post-menopausal women. Osteoporosis, characterized by a progressive reduction in bone mass is linked to female gender, increased age, and estrogen deficiency. The transition to menopause has also been demonstrated to be a period of increased risk for depressive symptoms even in women with no prior history of depression. Vasomotor symptoms, osteoporosis, depression—each can impair a woman’s functioning and quality of life. As women are expected to live well into their 80s, it is essential that healthcare providers recognize and manage these changes. In this neuroscienceCME webcast, the experts will explore each of these clinical challenges that may face women in the midlife transition and provide insights and strategies for improving patient care.

---

• Dennerstein L, Soares CN. The unique challenges of managing depression in mid-life women. World Psychiatry 2008;7:137-142.
• National Institutes of Health. Osteoporosis Prevention, Diagnosis, and Therapy. Available at: http://consensus.nih.gov/2000/2000Osteoporosis111html.htm. 2000.

Supplemental information: North American Menopause Society Guidelines on Hormone Therapy and Osteoporosis http://www.menopause.org/aboutmeno/consensus.aspx

Activity Goal

Explore the clinical challenges facing women during midlife transition and translate evidence-based data into improved outcomes and quality of life.

Learning Objectives

At the end of this CE activity, participants should be able to:

• Examine the latest evidence on the recognition and management of hormone-related changes that can affect women during midlife and the continuum of care needed to appropriately care for these patients.
• Describe the impact of untreated vasomotor symptoms, osteoporosis, and depression in midlife women.
• Compare and contrast treatment options to help manage these conditions.

Target Audience

Physicians, physician assistants, nurse practitioners, nurses, psychologists, social workers, certified case managers, pharmacists, and other healthcare professionals interested in women’s health.

Financial Support

This activity is supported by an educational grant from Lilly USA, LLC. For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CME Outfitters, LLC, designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.

CNE Credit (Nurses):
This continuing nursing education activity was approved by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

It has been assigned approval code 7ZDQ9Q-10. 1.0 contact hours will be awarded upon successful completion.

CEP Credit (Psychologists):
CME Outfitters is approved by the American Psychological Association to sponsor continuing education for psychologists. CME Outfitters maintains responsibility for this program and its content. (1.0 CE credits)

NASW Credit (Social Workers):
This program was approved by the National Association of Social Workers (provider #886407722) for 1 continuing education contact hour.

CCMC Credit (Certified Case Managers):
This program has been approved for 1 hour by the Commission for Case Manager Certification (CCMC).

CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs) Universal Program Number: 376-000-09-026-H01-P
Activity Type: knowledge-based

Post-tests, credit request forms, and activity evaluations can be completed online at www.neuroscienceCME.com (click on the Testing/Certification link under the Activities tab—requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required). Otherwise, participants should fully complete and return both the credit request form and activity evaluation located within the course guide for this activity. A certificate or statement of credit will be mailed within 4–6 weeks to all who successfully complete these requirements. This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neuroscienceCME.com/technical.asp.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Soares has disclosed that he has received grant/research support from Allergen National Centre of Excellence, AstraZeneca Pharmaceuticals LP, Canadian institute of Health Research (CIHR), Eli Lilly and Company, Hamilton Community Foundation, H. Lundbeck A/S, National Alliance for Research on Schizophrenia and Depression (NARSAD), Physicians Services Incorporated (PSI) Foundation, and Wyeth Pharmaceuticals. He serves as a consultant to Bayer Healthcare Pharmaceuticals, Eli Lilly and Company, and Wyeth Pharmaceuticals. He is on the speakers bureaus of AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, and Wyeth Pharmaceuticals. He is on the advisory boards of AstraZeneca Pharmaceuticals LP, Bayer Healthcare Pharmaceuticals, Eli Lilly and Company, and Wyeth Pharmaceuticals.

Dr. Adachi has disclosed that he serves as a consultant to Amgen Inc., AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Nycomed, Pfizer Inc., Proctor & Gamble, Roche, Sanofi-aventis, Servier, and Wyeth Pharmaceuticals. He has received support for clinical trials from Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Pfizer Inc., Proctor & Gamble, Sanofi-aventis, Roche, and Wyeth Pharmaceuticals.

Unlabeled Use Disclosure

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

CME Outfitters, LLC, the faculty, and Lilly USA, LLC, do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).

WC-008-111709-11